Analysts: ResMed Inc (RMD.N)

RMD.N on New York Stock Exchange

48.38USD
1 Aug 2013
Price Change (% chg)

$0.73 (+1.53%)
Prev Close
$47.65
Open
$48.50
Day's High
$49.41
Day's Low
$47.90
Volume
522,336
Avg. Vol
238,662
52-wk High
$51.39
52-wk Low
$31.08

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.56 June 2 Aug 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 1 1 1
(2) OUTPERFORM 4 3 3 3
(3) HOLD 7 7 7 9
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.38 2.55 2.55 2.62

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 7 371.53 375.00 367.00 368.51
Quarter Ending Dec-13 7 410.84 422.00 405.55 397.45
Year Ending Jun-13 13 1,514.19 1,545.00 1,505.44 1,479.62
Year Ending Jun-14 13 1,657.12 1,702.00 1,624.20 1,613.01
Earnings (per share)
Quarter Ending Sep-13 7 0.56 0.61 0.53 --
Quarter Ending Dec-13 7 0.63 0.68 0.59 0.48
Year Ending Jun-13 10 2.25 2.27 2.18 1.91
Year Ending Jun-14 10 2.52 2.75 2.38 2.09
LT Growth Rate (%) 4 16.40 20.01 15.00 15.77

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 387.68 383.58 4.10 1.06
Quarter Ending Dec-12 363.76 376.54 12.78 3.51
Quarter Ending Sep-12 341.14 339.73 1.41 0.41
Quarter Ending Jun-12 368.36 371.93 3.57 0.97
Quarter Ending Mar-12 339.56 349.07 9.51 2.80
Earnings (per share)
Quarter Ending Mar-13 0.57 0.59 0.02 4.24
Quarter Ending Dec-12 0.51 0.54 0.03 5.76
Quarter Ending Sep-12 0.46 0.50 0.04 9.79
Quarter Ending Jun-12 0.49 0.55 0.06 12.57
Quarter Ending Mar-12 0.41 0.46 0.05 12.20

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-13 371.53 373.07 373.28 373.28 368.51
Quarter Ending Dec-13 410.84 412.26 412.26 412.26 397.45
Year Ending Jun-13 1,514.19 1,514.34 1,514.41 1,513.68 1,479.62
Year Ending Jun-14 1,657.12 1,660.59 1,664.91 1,665.14 1,613.01
Earnings (per share)
Quarter Ending Sep-13 0.56 0.55 0.55 0.55 --
Quarter Ending Dec-13 0.63 0.61 0.61 0.61 0.48
Quarter Ending Jun-13 2.25 2.25 2.25 2.25 1.91
Quarter Ending Jun-14 2.52 2.49 2.49 2.48 2.09

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-13 0 3 0 4
Quarter Ending Dec-13 0 3 0 4
Year Ending Jun-13 0 2 1 2
Year Ending Jun-14 0 3 0 4
Earnings
Quarter Ending Sep-13 2 0 2 0
Quarter Ending Dec-13 2 0 2 1
Year Ending Jun-13 1 2 2 3
Year Ending Jun-14 2 1 3 1

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$58.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Stock Traders Daily
$495.00
Provider: MacroRisk Analytics/EconomicInvestor
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks